Haleon plc (HLN) Stock Analysis

Price updated 2 days ago · SEC data refreshed 3 months ago · Not investment advice

Haleon plc

HLN Consumer Defensive Soaps & Cleaning Products📄 SEC filings ↗
Valuation N/A
▾ What's in the 58/100 risk score? (higher = riskier)
Smart money (short interest + insider buying) (55%) 65/100 → +35.8
Macro backdrop (VIX, curve, credit, fear/greed + week-over-week momentum) (45%) 50/100 → +22.5
Total58/100

Contributions (weight × component score) sum to the total. This near-term score now includes fundamental health (leverage, FCF trend). See the Financial Health section for the full balance-sheet read.

💵 Price $9.19 · 2 days ago 📄 Financials SEC EDGAR · refreshed 3 months ago

How to read HLN (pre-profit growth)

This company is reinvesting instead of generating profit, so a standard DCF cannot price it. The useful question is whether the growth the market is paying for is achievable — and whether the company can fund itself until then.

Where to start — the sections that matter most for this stock
  1. 1 Reverse-DCF — the growth the price demands ↓
    It shows exactly how fast the business must grow to justify today's price. Compare that to what comparable companies have actually achieved.
  2. 2 Cash runway ↓
    Can it reach profitability before it has to raise money and dilute shareholders?
  3. 3 Interactive calculator ↓
    Set your own growth + margin assumptions and see what the business would be worth if you are right.
Or — what are you trying to decide?
A note on process: fear-driven decisions — including fear of missing out — tend to be the expensive ones. A stock up 10% a day for three days is excitement, not evidence. Whichever reader you are, the data below is there to be checked before anything is decided.
🚀
"It's surging — should I chase it?"
The momentum / FOMO trade. Before you chase, see whether the people who know it best are quietly selling into the rally.
🏷️
"Is it a cheap bargain?"
The deep-value trade. How far below assets and our value it trades — and whether it's cheap for a reason.
ⓘ HLN is a thinly-disclosed company trading over-the-counter

It files little or nothing with the SEC — so our cash-flow models, financial statements, and U.S. insider data (Form 4) don't apply. What's still real: the live U.S. price and short positioning. Here's what we could pull from other sources:

📑 Read the real filings: latest SEC 6-K ↗

Identity, share count and tier from FINRA + OTC Markets; not a substitute for the home-market financial statements. Thin U.S. disclosure + OTC trading is itself a risk factor.

ⓘ Why does HLN trade at $9.19?

Haleon plc has 8.95 billion shares outstanding. At $9.19 per share, the market values all outstanding HLN equity at $82.3 billion. That's market capitalization, not enterprise value — enterprise value also accounts for debt and cash (HLN carries little or no debt, so the two are close here). The share price by itself tells you almost nothing — a company can pick any share price by splitting or issuing more shares. What matters is the total value (Market Cap?Market Cap — The total dollar value the market is assigning to the entire company.
Why it matters: This is the number that actually matters when comparing companies. Two companies with the same business but different share counts have the same market cap.
Reference: Mega cap >$200B · Large $10–200B · Mid $2–10B · Small $300M–2B · Micro <$300M
Full explanation →
) compared to what the business actually produces. This page values HLN in Per Share?Per Share — A company-level figure divided by total shares — what one share represents.
Why it matters: Per-share metrics are the only way to fairly compare two companies with different share counts.
Full explanation →
economics — what each share represents of the underlying business. Play with the share-price calculator on the homepage →

Loading insider & short-seller data…
Checking filings for failure warnings…

How does HLN stack up against its closest peers?

We take the 7 same-industry companies most similar to HLN (similar size) and check what investors are paying for each dollar of their revenue (or profits). If HLN is much more expensive on the same yardstick, that's a red flag — unless you have a specific reason it deserves a premium. For a leveraged business, EV/EBIT and FCF yield (both in the table) are usually more reliable than EV/Sales, because revenue multiples ignore differences in margins and debt.

▾ What's "EV / Sales" in plain English?

EV (Enterprise Value) = market cap + total debt − cash. It's "what you'd pay to buy the entire company outright" — you pay the market cap to shareholders and take over their debt, but you keep their cash. EV is fairer than market cap alone because it includes the debt the new owner inherits.

EV / Sales = EV ÷ annual revenue. So "2.5×" means investors pay $2.50 of enterprise value per $1 of yearly sales. Higher = market is paying more per dollar of sales (usually because they expect future growth or fat margins).

p25 / median / p75 are the 25th, 50th (middle), and 75th percentile of the peers' multiples. Half the peers fall between p25 and p75. The median (p50) is the typical peer — that's the benchmark we compare to.

What peers trade at (p25 / median / p75)
EV / Sales?EV / Sales — For every $1 of yearly revenue, this is how many dollars investors pay to own the whole business (including debt).
Why it matters: Works for pre-profit growth companies where P/E and FCF don't apply. The most apples-to-apples cross-company multiple because it ignores accounting choices.
Reference: 1–3x for mature companies · 4–10x for software/SaaS · 10–20x for hypergrowth · >20x is rare and demanding
Full explanation →
2.3x / 3.9x / 4.3x
EV / Gross Profit?EV / Gross Profit — Enterprise value divided by gross profit — the multiple paid for what each dollar of sales contributes after direct costs.
Why it matters: More refined than EV/Sales for high-margin businesses (software, marketplaces) where gross margin is the real economic engine.
Reference: 8–15x for SaaS · 15–25x for hypergrowth software · >30x demanding
Full explanation →
3.9x / 6.2x / 6.5x
EV / EBIT?EV / EBITDA — Enterprise value divided by earnings before interest, tax, depreciation, and amortization.
Why it matters: A classic "what would a private buyer pay" multiple — used in M&A. Strips out tax and capital-structure noise.
Reference: 8–12x for mature businesses · 15–25x for growth · Below 5x often signals distress
Full explanation →
16.2x / 21.0x / 24.2x

Bold middle number = median peer. Half the peers trade above it, half below. Computed over 7 same-industry peers; implausible multiples excluded.

Peer-implied value check
Peer-implied price isn't available for HLN right now. The multiples table above still works as context.

⚠️ Important caveat: peer multiples only work if the peers are genuinely comparable. Always check the peer list below — if the auto-picker grabbed micro-caps or unrelated businesses, the comparison is noise. A medical-device giant priced against tiny biotech startups won't produce a useful signal.

▾ View peer list (7)
Ticker Company Industry Mcap EV/Sales EV/GPEV/EBIT FCF Yield
CL COLGATE PALMOLIVE CO Soaps & Cleaning Products $72.1B 3.9x 6.5x24.2x 4.8%
ECL ECOLAB INC. Soaps & Cleaning Products $72.0B 4.5x 26.6x 2.4%
UL UNILEVER PLC Soaps & Cleaning Products $135.3B 2.9x 6.2x16.2x 5.5%
KVUE Kenvue Inc. Soaps & Cleaning Products $33.2B 2.3x 3.9x14.3x 4.8%
EL ESTEE LAUDER COMPANIES INC Soaps & Cleaning Products $32.0B 2.2x 3.0x 1.1%
CHD CHURCH & DWIGHT CO INC /DE/ Soaps & Cleaning Products $22.7B 4.0x 9.0x23.1x 4.4%
PG PROCTER & GAMBLE Co Soaps & Cleaning Products $337.7B 4.3x 18.8x 4.2%

Quality & solvency checks

Cheap stocks can be cheap for a reason. These screens warn when a low valuation comes paired with structural fragility.

Altman Z-Score?Altman Z-Score — A bankruptcy-risk score combining 5 financial ratios into one number. Predictive of bankruptcy within 2 years.
Why it matters: Cheap-looking stocks (low P/E or P/B) often have low Z-scores because the market knows the company is dying. Z-score warns you before you fall into a value trap.
Reference: > 3.0 = safe zone · 1.81–3.0 = grey zone · < 1.81 = distress zone
Full explanation →
Not available for this filer

The Z-score needs working capital, retained earnings, EBIT, sales and total assets from the latest balance sheet, and at least one of those isn't reported in machine-readable form here — common for foreign private issuers. We leave it blank rather than compute a distress verdict from an estimated input. It doesn't affect the reported figures in the financial tables below.

Piotroski F-Score?Piotroski F-Score — A 9-point quality checklist scoring profitability, leverage, and operating efficiency.
Why it matters: High score = fundamentals improving. Low score = deteriorating. Especially powerful for filtering cheap stocks: cheap + high F-score historically outperforms; cheap + low F-score is often a value trap.
Reference: 7–9 = strong · 4–6 = mediocre · 0–3 = weak
Full explanation →
Not available for this filer

The F-score compares two consecutive years of income, cash-flow and balance-sheet data. We have 0 years of income data for this filer, but no machine-readable cash-flow statement or balance sheet — so several of the nine checks have no input at all. We show nothing rather than score a partial year against itself. The reported figures in the financial tables below are unaffected.

Price$9.19
Model IVNot applicable — DCF couldn't price this stock. The other valuation lenses on this page (reverse-DCF, peers, sector lens — whichever apply to this filer) carry the read instead.

A standard discounted cash flow?DCF — Discounted Cash Flow — sums up all future cash a business will produce, adjusted for the fact that future dollars are worth less than dollars today.
Why it matters: It is the most fundamentally honest valuation method when applicable — but only works for companies with predictable, positive cash flow.
Reference: Best for: mature, profitable businesses. Fails for: pre-profit growth, banks, REITs.
Full explanation →
(DCF) valuation is not meaningful for Haleon plc because the model projects negative free cash flow?Free Cash Flow (FCF) — Operating cash flow minus capital spending: cash left after a company covers operating costs, taxes and interest and reinvests in the business — but BEFORE repaying debt principal or paying dividends. The cash actually available to investors.
Why it matters: A company can show big profits on paper while burning through cash. FCF is what actually fills the bank account.
Reference: Healthy mature businesses convert 8–15% of revenue into FCF · Growth companies often negative
Full explanation →
per share, indicating it's not currently generating profits sufficient for a positive equity value. Investors are likely focused on the company's ability to grow revenue and eventually achieve consistent positive free cash flow, rather than current profitability. The market may be assigning value to the potential for new product development and market expansion in consumer health, which is not captured in the backward-looking model. The #1 quantifiable risk is the persistent negative free cash flow, which implies a speculative valuation.

⚠️ FCF negative: revenue/margin growth model projects future cash flows from revenue trajectory.

As of 3 months ago

Anatomy of a share

What you're buying per share. Bars are at the same scale so you can see the relative size of revenue, costs, cash flow, and debt — not just read them in a table.

Per-share economics aren't reliable for this filer. Its income statement or share count isn't fully reported to SEC EDGAR (common for foreign private issuers and thinly-disclosed OTC names), so we don't break it down per share here — the figures would be misleading. See the financial tables below for what is reported.

What you actually need to decide

Every stock price is a disagreement. Here's the single thing that must go right for the bulls, the single thing that breaks the thesis, and the concrete signposts to watch so you can update your view as real results arrive.

🐂 The Bull Case
Operating cash flow must turn positive and grow consistently to validate the modeled revenue trajectory and achieve a positive equity value.
🐻 The Bear Case
Continued negative free cash flow?Free Cash Flow (FCF) — Operating cash flow minus capital spending: cash left after a company covers operating costs, taxes and interest and reinvests in the business — but BEFORE repaying debt principal or paying dividends. The cash actually available to investors.
Why it matters: A company can show big profits on paper while burning through cash. FCF is what actually fills the bank account.
Reference: Healthy mature businesses convert 8–15% of revenue into FCF · Growth companies often negative
Full explanation →
implies that the company is burning cash, which could necessitate further financing or dilute existing shareholders if not reversed.
📌 Signposts to watch — update your view as these print
  • Quarterly revenue growth rates
  • Improvement in operating cash flow
  • New product launch success

Management & Leadership

Brian McNamara has served as the Chief Executive Officer of Haleon plc since its spin-off from GSK in 2022. He previously led GSK Consumer Healthcare. Dave Lewis is the Non-Executive Chair.

Brian McNamara
Chief Executive Officer
Dave Lewis
Non-Executive Chair

What They Make

Haleon plc is a global consumer healthcare company that develops and supplies a broad portfolio of health and wellness products, including oral care, pain relief, respiratory, and digestive health items, sold to consumers worldwide.

End Markets

Consumer HealthOver-the-Counter MedicinePersonal Care

Revenue Drivers

Oral Health products
Pain Relief products
Vitamins, Minerals and Supplements
Market Cap: 82.3BBeta: 0.40

Why Is It Priced Like This?

Why Customers Pay

Trusted brands for everyday health needs
Accessibility of over-the-counter solutions
Innovation in consumer health products
No discounted-cash-flow value for this filer No machine-readable cash-flow statement in this filer's EDGAR submissions — common for foreign private issuers (20-F/6-K). That makes a discounted-cash-flow valuation impossible: there is no free cash flow to discount. It does not affect the income-statement or balance-sheet figures below.

The income statement and balance sheet are also too incomplete here to substitute another lens honestly, so this page carries price, momentum and disclosure facts only.

The market is likely pricing Haleon based on expectations for future revenue growth (modeled at 15.0%) and the long-term potential of its established consumer health brands, despite the current negative free cash flow?Free Cash Flow (FCF) — Operating cash flow minus capital spending: cash left after a company covers operating costs, taxes and interest and reinvests in the business — but BEFORE repaying debt principal or paying dividends. The cash actually available to investors.
Why it matters: A company can show big profits on paper while burning through cash. FCF is what actually fills the bank account.
Reference: Healthy mature businesses convert 8–15% of revenue into FCF · Growth companies often negative
Full explanation →
per share. The 'franchise/durability score 0/5' suggests a lack of clear competitive advantage, making future growth and profitability critical. The market may be assigning value to the potential for successful new product launches and geographic expansion within the consumer health sector, which is not in the model.

Business Model & Valuation

How They Make Money

Oral Health products
Pain Relief products
Vitamins, Minerals and Supplements

Growth / Revenue DCF

No cash flow statement data available - using revenue/margin growth model as fallback.

Show advanced inputs
Revenue Growth15.0%

What this model does NOT do: this is a consolidated owner-earnings FCF model. Standalone segment assumptions: none. It does not project its revenue segments independently; their combined effect is embedded in the historical revenue and cash-flow trend the model extrapolates. The calculator above can only approximate a segment's impact through the single consolidated growth rate — it cannot model any one line separately. For a true segment-level view, build a separate model from the company's segment disclosures.

Maturity & Competitive Position

Growth / re-investment phase

Moat Signals

Brand recognition in consumer health
Extensive distribution networks
R&D in consumer health innovation

The model projects future cash flows from a revenue trajectory, implying a focus on revenue growth rather than current earnings per share.

Geography & Markets

Haleon plc operates globally, with a significant presence across various international markets. While specific geographic mix percentages are not available, its products are widely distributed in North America, Europe, and emerging markets.

Geographic Risks

Global economic downturn impacting consumer spending
Intense competition in the consumer health sector

Market Signals

These are timing signals, not value signals — they describe the stock's recent price behavior, not what the business is worth. Use them for the "the thesis looks good, but is now the moment?" question. Each tile below explains what it's saying.

Model neutral, tape bearish
RSI?RSI — Relative Strength Index — a 0-100 momentum gauge. Above 70 = overbought; below 30 = oversold.
Why it matters: Short-term contrarian indicator. Extreme readings often precede mean reversion, though not always.
Reference: 30–70 normal · >70 overbought · <30 oversold
Full explanation →
(14)
40.2NeutralMomentum is balanced — neither overbought nor oversold.
MACD?MACD — Moving Average Convergence Divergence — compares a fast and a slow price trend to gauge momentum direction.
Why it matters: When the fast line crosses above the slow line, short-term momentum is turning up; below, turning down. A timing cue, not a value signal.
Reference: Line above signal = bullish momentum · below = bearish
Full explanation →
BullishLine above signalThe fast trend is above the slow trend — short-term momentum is currently upward.
50-Day Average$9.52Price below (-3.5%)Price below its 50-day average = near-term downtrend.
200-Day Average$9.77Price belowThe 200-day line is the long-term trend divider — above it is generally considered a bull market for the stock.
50 vs 200 CrossDeath50-day below 200-dayA "death cross" — the medium trend is below the long trend (often read as bearish).

Technicals describe price, not the business. A great company can have a "bearish" tape (a buying chance) and a weak one a "bullish" tape (a trap). Pair these with the valuation and health sections above.

Data Quality & Risk Flags (3 notes — click to expand/collapse)

Guardrail Notes (3)
  • FCF negative: revenue/margin growth model projects future cash flows from revenue trajectory.
  • INVARIANT: weighted IV is non-positive. Model may not be appropriate.
  • Model implies no positive equity value under these assumptions. Valuation is speculative/low-confidence.

Financial Statements (5-year tables — click to expand)

From Haleon plc's SEC filings (EDGAR).

Similar companies worth a look

Same sector and industry, similar fundamentals shape. Verify everything yourself — this list is computed mechanically and does not reflect our judgment about whether any of these are a good investment.

PG
Methodology by Pouyan Golshani, MD — founder of Gighz. Savng was built by a physician for busy professionals: every number on this page comes from SEC filings (EDGAR) and FINRA data through transparent, rules-based models — no analyst opinions, no hidden inputs. How we calculate every number →
⚠️ Not investment advice. Automated model outputs, last refreshed May 30, 2026 (the analysis-refresh date, not the latest filing period). All models have blind spots. Full disclaimer →
🔔 Follow $HLN — free insider alerts
One email when an insider buys $HLN on the open market with their own cash — or notably sells outside a scheduled plan. Routine and automated trades filtered out. Follow up to 3 stocks free; Portfolio Watch covers your whole list plus valuation & risk alerts. Double opt-in, unsubscribe anytime.